Kazakhstan makes breakthrough in early prostate cancer detection
New radiopharmaceutical enables early-stage prostate cancer diagnosis, outpacing traditional imaging and boosting detection rates
ASTANA, Kazakhstan (MNTV) — Kazakhstan has introduced a pioneering medical technology that could significantly improve early detection of prostate cancer, one of the most common cancers among men. The breakthrough centers on a next-generation radiopharmaceutical developed at the Nuclear Medicine Center of the Medical Center Hospital under the President’s Affairs Administration.
According to a report by Silk Way TV, the newly developed compound allows doctors to identify prostate cancer in its earliest stages—well before it becomes visible through standard diagnostic tools such as ultrasound, MRI, or CT scans. Experts hail the innovation as a major milestone for the country’s nuclear medicine capabilities.
“It took us about six months to introduce this radiopharmaceutical,” said Baurzhan Abyshev, Head of the Cyclotron-Production Complex at the center. “In global practice, this process can take up to two years. From raw materials to final production, we’ve maintained complete oversight in-house, ensuring the highest quality standards.”
The drug not only offers high contrast imaging but also benefits from a longer half-life, enabling broader use and allowing for more patients to be examined daily. During its pilot phase, the first five patients successfully underwent diagnostic procedures using the compound.
Aigul Saduakassova, Head of the Nuclear Medicine Center, noted that the new method has increased the detection rate of prostate cancer by two to three times. “Currently, more than 8,000 men in Kazakhstan live with this disease, and each year we see 500 to 800 new cases,” she said.
The Nuclear Medicine Center currently produces ten different radiopharmaceuticals aimed at improving the accuracy and speed of cancer diagnosis across the country. Officials hope this latest development will not only improve patient outcomes but also position Kazakhstan as a regional leader in nuclear medical technology.
Have Your Say!
Have you been affected by the issues raised in this story? Please share your experiences by emailing haveyoursay@soundvision.com.
Please include a contact number if you are willing to speak to a Muslim Network TV’s representative. You can also get in touch in the following ways:
Tweet: @MuslimNetworkTV
We must take charge of our narrative. Research indicates that 92% of their Muslim coverage is negative. Help us change that.
